Inflammatory bowel disease and colon cancer: A Review

Digestive Diseases

Volumn 15, Issue 4-5, 1997, Pages 243-252

  Jain, Sushil K ^a   Peppercorn, Mark A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Colitis; Colorectal neoplasms; Crohn s disease; Inflammatory bowel diseases; Ulcerative

Indexed keywords

CANCER STAGING; COLON TUMOR; COLONOSCOPY; CROHN DISEASE; HUMAN; MASS SCREENING; PATHOLOGY; PROGNOSIS; REVIEW; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; CROHN DISEASE; HUMANS; MASS SCREENING; NEOPLASM STAGING; PROGNOSIS;

EID: 0031182140     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171601     Document Type: Article

References (65)

1. Roscnqvist H, Ohrling H, Lager-crantz R, Edling N: Ulcerative colitis and carcinoma coli. Lancet 1959; i;906-908.
2. Edwards FC, Truelove SC: Course and prognosis of ulcerative colitis. IV: Carcinoma of colon. Gut 1964: 5:15-22.
3. MacDougall IPM: The cancer risk in ulcerative colitis. Lancet 1964;ii: 655-658.
4. Ekbom A, Helmick C, Zack M, Adami H-O: Ulcerative colitis and colorectal cancer: A population-based study. N Engl J Med 1990:323: 1228-1233.
5. Weedon OD, Shorter RG, Illstrup DM, Huizenga KA, Taylor WF: Crohn's disease and cancer. N Engl J Med 1973:289:1099-1103.
6. Softley A, Clamp SE, Watkinson G, Boucher LAD, Myren J, DcDombal FT: The natural history of inflammatory bowel disease: Has there been a change in the last 20 years? Scand J Gastroenterol 1988:23:20-23.
7. Richards ME, Rickcrt RR, Nance FC: Crohn's disease-associated carcinoma. Ann Surg 1989:209:764-773.
8. Ekbom A, Helmick C, Zack M, Adami H-O: Increased risk of largc-bow-el cancer in Crohn's disease with colonic involvement. Lancet 1990: 336:357-359.
9. Devrocde GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB: Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971:285:17-21.
10. Katzka I, Brody RS, Morris E, Katz S: Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice. Gastroenterology 1983:85:22-29.
11. Madjilcssi SH, Farrer RG, Easley KA, Beck GJ: Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986:58:1569.
12. Gydc SN, Prior P, Allan RN, Stevens A, Jewell DP. Truelove SC. Lofberg R. Brostrom O. Hellers G: Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut 1988: 29:206-217.
13. Lcnnard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB: Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years. Gut 1990:31:800-806.
14. Grccnstein AJ, Sachar DB, Smith H, Pucillo A, Papatcstas AE, Kreel I, Gcllcr SA, Janowitz HD, Aufses AH Jr. Cancer in universal and left-sided ulcerative colitis: Factors determining risk. Gastroenterology 1979:77:290-294.
15. Nugent FW, Haggitl RC, Gilpin PA: Cancer surveillance in ulcerative colitis. Gastroenterology 1991:100: 1241-1248.
16. Levin B: Inflammatory bowel disease and colon cancer. Cancer 1992: 70:1313-1316.
17. Langholz E, Munkholnt P, David-scn M, Binder V: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992:103:1444-1451.
18. Lcnnard-Jones JE: Cancer risk in ulcerative colitis: Surveillance or surgery. Br J Surg 1985;72(suppl):84-86.
19. Collins RH, Feldman M, Fordtran JS: Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: A critical review. N Engl J Med 1987:316:1654-1658.
20. Binder V, Hendriksen C, Kreiner S: Prognosis in Crohn’s disease - based on results from a regional patient group from the county of Copenhagen. Gut 1985:26:146-150.
21. Kvist N, Jacobsen O, Norgaard P, Ockelmann HH, Kvist HK, Schou G, Jarnum S: Malignancy in Crohn's disease. Scand J Gastroenterol 1986:21:82-86.
22. Gollop JH, Phillips SF, Melton U III, Zinsmeister AR: Epidemiologic aspects of Crohn's disease: A population based study in Olmsted County. Minnesota, 1943-1982. Gut 1988:29:49-56.
23. Fireman Z, Grossman A, Lilos P, Hacohen D, Bar Meir S, Rozen P, Gilat T: Intestinal cancer in patient’s with Crohn's disease. A population study in central Israel. Scand J Gastroenterol 1989:24:346-350.
24. Grccnstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH: A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981:48:2742-2745.
25. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JAH, Allan RN: Malignancy in Crohn's disease. Gut 1980;21:1024-1029.
26. Gillen CD, Walmslcy RS, Prior R, Andrews HA, Allan RN: Ulcerative colitis and Crohn’s disease: A comparison of the colorectal cancer risk in extensive colitis. Gut 1994:35: 1590-1592.
27. Choi PM, Zclig MP: Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention. Gut 1994;35:950-954.
28. Vogclstein B, Fcaron ER, Hamilton SR, Kern SE, Prcisinger AC, Lep-pcrt M, Nakamura Y, White R, Smits AMM, Bos JL: Genetic alterations during colorectal tumor development. N Engl J Med 1988:319: 525-532.
29. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabino-vitch PS: c-Kt-ra.v mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990:99:416-420.
30. llzkowitz SH, Grcenwald B, Mcltzer SJ: Colon carcinogenesis in inflammatory bowel disease. Inflamm Bowel Dis 1995:1:142-158.
31. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, Hamilton S, Vogclstein B: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigencsis. Cancer Res 1990:50:7717-7722.
32. Burmer GC, Rabinovitch PS, Hag-gitl RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE: Neoplastic progression in ulcerative colitis: Histology, DNAcontent. and loss of a p53 allele. Gastroenterology 1992;103:1602-1610.
33. Butt JH, Konishi F, Morson BC, Lennard-Joncs JE, Ritchie JK: Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. DigDisSci 1983:28:18-26.
34. Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Len-nard-Jones JE: Lower gastrointestinal malignancy in Crohn's disease. Gut 1994:35:347-352.
35. Hamilton SR: Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985:89:398-407.
36. Pctras RE, Mir-Madjlessi SH, Farmer RG: Crohn’s disease and intestinal carcinoma: A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 1987:93:1307-1314.
37. Riddell RIH, Goldman H, Ransohoff DF, Appelntan HD, Fcnoglio CM, Haggitt RC, Ahrcn C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardlcy JH: Dysplasia in inflammatory bowel disease: Standardised classification with provisional clinical applications. Hum Pathol 1983:14:931-968.
38. Albert MB, Nochomovitz LE: Dysplasia and cancer surveillance in inflammatory bowel disease. Gastroenterol Clin North Am 1989:18: 83-97.
39. Allen DC, Hamilton PW, Watt PCH, Biggart JD: Morphomctrical analysis in ulcerative colitis with dysplasia and carcinoma. Histopa-tliology 1987;11:913-926.
40. Allen DC, Hamilton PW, Watt PCH, Biggart JD: Architectural morphometry in ulcerative colitis with dysplasia. Histopalhology 1988:12:611-621.
41. Melville DM, Jass JR, Shepherd NA, Northover JMA, Cepellaro D, Richman PI, Lennard-Joncs JE, Ritchie JK, Andersen SN: Dysplasia and deoxyribonucleic acid ancuploi-dy in the assessment of prccanccr-ous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology 1988:95: 668-675.
42. Dixon MF, Brown LJ, Gilmour HM, Price AB, Smeeton NC, Talbot IC, Williams GT: Observer variation in the assessment of dysplasia in ulcerative colitis. Histopalhology 1988:13:385-397.
43. Connell WR, Lennard-Joncs JE, Williams CB, Talbot IC, Price AB, Wilkinson KH: Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-944.
44. Axon ATR: Cancer surveillance in ulcerative colitis: A time for reappraisal. Gut 1994:35:587-589.
45. Brostrom O, Lofberg R, Osi A, Rei-chard H: Cancer surveillance of patients with long-standing ulcerative colitis: A clinical, endoscopia!, and histological study. Gut 1986:27: 1408-1413.
46. Manning AP, Bulgint OR, Dixon MF, Axon AIR: Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut 1987:28:1489-1494.
47. Ransohoff DF, Riddell RH, Levin B: Ulcerative colitis and colonic cancer: Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985; 28:383-388.
48. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroedcr KW, Welling DR, Spencer MP, Zinsmci-sler AR: Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance. Dis Colon Rectum 1992:35:950-956.
49. Richards ME, Rickcrt RR, Nance FC: Crohn's disease-associated carcinoma. Ann Surg 1989:209:764-773.
50. Frcko D, Lazarus SS, Dotan J, Reingold M: Early presentation of carcinoma of the small bowel in Crohn's disease ('Crohn’s carcinoma’). Case reports and review of the literature. Gastroenterology 1982:82:783-789.
51. Warren R, Barwick KW: Crohn’s colitis with adenocarcinoma and dysplasia. Am J Surg Pathol 1983:7: 151-159.
52. Korclitz BI, Lauwers GY, Sommers SC: Rectal mucosal dysplasia in Crohn’s disease. Gut 1990:31:1382-1386.
53. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB: Cancer in colitis: Assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977:73:1280-1289.
54. Vcmulapalli R, Lance P: Cancersurveillance in ulcerative colitis: More of the same or progress? Gastroenterology 1994:107:1196-1199.
55. Bernstein CN, Shanahan F, Weinstein WM: Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? lancet 1994:343:71-74.
56. Lashner BA, Kane SV, Hammer SB: Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study. Am J Gastroenterol 1990:85: 1083-1087.
57. Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC: Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993: 105:418-424.
58. Giardiello FM, Gurbuz AK, Bayless TM, Yardley JH: Colorectal cancer in ulcerative colitis: Kffect of a cancer prevention strategy on survival (abstract). Gastroenterology 1993: 104:705.
59. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine OS, Dean PJ, Kimmey M, Perera DR, Rabinovitch PS: DNA aneu-ploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-1620.
60. Rozen P, Baratz M, Fcfer F, Gilat T: Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995:108:1361-1370.
61. Lofberg R, Brostrom O, Karlen P, Osi A. Tribukail B: DNA aneuploi-dy in ulcerative colitis: Reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 1992:102:1149-1154.
62. DuBois D, Rosenberg IR, Ho I, Chen A, Itzkowitz SH: Expression of sialosyl-Tn in surveillance biopsies of patients with ulcerative colitis-associated colorectal cancer but no prior dysplasia (abstract). Gastroenterology 1994:106:1023.
63. Grcenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VI, McDaniel T, Newkirk C, Resau JH, Mcltzer SJ: Loss of heterozygosity affecting the p53, Kb. and mcc/upc tumor suppressor gene loci in dys-plastic and cancerous ulcerative colitis. Cancer Res 1992:52:741-745.
64. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A: Colonoscopic surveillance in long-standing total ulcerative colitis: A 15-ycar follow-up study. Gastroenterology 1990,99: 1021-1031.
65. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B: Carcinoma and DNA aneuploidy in Crohn's colitis: A histological and flow cytometric study. Gut 1991:32:900-904.